Nasdaq

Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder

ADELAIDE, Australia and CAMBRIDGE, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, ...
collider

The MCU's Phase 4 Needs an End Goal Fast

Charlie is a Feature writer based in the United Kingdom. Phase 3 of the MCU was undoubtedly the most important to date, and culminated in the epic Avengers: Endgame, which tied up a lot of loose ends ...
GameSpot

Marvel's Black Panther: Wakanda Forever To End Phase 4 Of The MCU

The Marvel Studios panel at Comic-Con kicked off with Kevin Feige announcing that the upcoming sequel Black Panther: Wakanda Forever will be the end of Phase 4. When Phase 4 was initially announced in ...
collider

Marvel's Phase 4 Ends With She-Hulk and Black Panther: Wakanda Forever

Marco Vito Oddo is a writer, journalist, and amateur game designer. Passionate about superhero comic books, horror films, and indie games, he formally worked as a Senior Writer for Collider. When he's ...
Nasdaq

Chemomab Completes Successful End-of-Phase 2 Meeting and Aligns with FDA on Clear and Efficient Path to Potential Regulatory Approval for Nebokitug (CM-101) in Primary ...

Single Positive Phase 3 Trial Designed to Support Full Regulatory Approval, For the First Time Providing Regulatory Clarity in PSC and Positioning Nebokitug to Potentially Become the First ...
Morningstar

PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis

Feedback from U.S. Food and Drug Administration (FDA) supports advancement into a pivotal Phase 3 trial and a 505(b)(2) regulatory pathway Phase 3 SURPASS-IPF trial remains on track to be initiated by ...